TRVI icon

Trevi Therapeutics
TRVI

Overview Fund Activity

53 hedge funds and large institutions have $117M invested in Trevi Therapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+17
Holders Change %
+47.22%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
16
Reduced
8
Closed
5
Calls
$47K
Puts
–
Net Calls
+$47K
Net Calls Change
+$133K

Top Buyers

1
BlackRock
1
BlackRock
New York
$5.34M
2
OM
2
Opaleye Management
Massachusetts
$4.07M
3
State Street
3
State Street
Massachusetts
$1.63M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.86M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.57M

Top Sellers

1
FFM
1
Fairmount Funds Management
Pennsylvania
$12.4M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$213K
3
MCM
3
MAI Capital Management
Ohio
$3.67M
4
Millennium Management
4
Millennium Management
New York
$0
5
IAM
5
Innovis Asset Management
Illinois
$103K
Name Holding Trade Value Shares
Change 		Shares
Change %
AIP
51
Ameritas Investment Partners
Nebraska
$8.22K +$8.22K +3,438 New
TRCT
52
Tower Research Capital (TRC)
New York
$3.59K +$3.59K +1,502 New
Fidelity Investments
53
Fidelity Investments
Massachusetts
$2.12K +$2.12K +886 New
Millennium Management
54
Millennium Management
New York
– -$110K -59,628 Closed
B
55
Bailard
California
– -$39.2K -21,200 Closed
Two Sigma Investments
56
Two Sigma Investments
New York
– -$23.9K -12,928 Closed
Squarepoint
57
Squarepoint
New York
– -$21.2K -11,474 Closed
1 2
3